Merit Medical
Merit Medical Systems, Inc., commonly referred to as Merit Medical, is a leading global provider of medical devices headquartered in the United States. Founded in 1987, the company has established a strong presence in key operational regions, including North America, Europe, and Asia. Specialising in interventional medicine, Merit Medical focuses on areas such as cardiology, radiology, and pain management. The company is renowned for its innovative core products, including catheter systems, access devices, and fluid management solutions, which are designed to enhance patient outcomes and streamline clinical procedures. Merit Medical's commitment to quality and innovation has positioned it as a trusted partner in the healthcare industry, with notable achievements in expanding its product portfolio and global reach.
DitchCarbon Score
How does Merit Medical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Merit Medical's score of 38 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Merit Medical's reported carbon emissions
In 2023, Merit Medical reported total carbon emissions of approximately 17,656,000 kg CO2e. This figure includes 3,072,000 kg CO2e from Scope 1 emissions and 14,584,000 kg CO2e from Scope 2 emissions. Notably, there were no reported Scope 3 emissions, apart from a minor contribution of 8,450 kg CO2e related to fuel and energy-related activities. Comparatively, in 2022, the company recorded total emissions of about 17,239,000 kg CO2e, with Scope 1 emissions at 3,101,000 kg CO2e and Scope 2 emissions at 17,795,000 kg CO2e. The 2021 emissions were higher, totalling approximately 18,200,000 kg CO2e, with Scope 1 at 3,415,000 kg CO2e and Scope 2 at 14,785,000 kg CO2e. The trend indicates a slight reduction in total emissions from 2021 to 2023. Merit Medical has not set specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The company’s emissions data is not cascaded from any parent organisation, indicating that these figures are independently reported by Merit Medical Systems, Inc. Overall, while Merit Medical has demonstrated some progress in reducing its carbon footprint, the absence of formal reduction targets suggests an opportunity for further commitment to climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 2,995,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 18,405,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Merit Medical is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
